NCT05740878

Brief Summary

The goal of this clinical trial is to compare the effect of local food-based oral nutritional supplements (ONS) containing immunonutrients (omega-3 and anthocyanins) on nutritional status and inflammatory response in head and neck cancer patients receiving radiotherapy. The main questions it aims to answer are:

  • Is there any effect of local food-based oral nutritional supplements (ONS) containing immunonutrients (omega-3 and anthocyanins) on the nutritional status?
  • Is there any effect of local food-based oral nutritional supplements (ONS) containing immunonutrients (omega-3 and anthocyanins) on inflammatory response? Participants will participants will receive ONS in powder form ready to brew as much as 2 servings per day for 3 weeks. Researchers will compare the effect of giving ONS containing immunonutrients compared to standard ONS to see the effect on nutritional status and inflammatory response

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2022

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

February 6, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 23, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2023

Completed
Last Updated

February 24, 2023

Status Verified

February 1, 2023

Enrollment Period

1.1 years

First QC Date

February 6, 2023

Last Update Submit

February 22, 2023

Conditions

Keywords

oral nutritional supplementimmunonutrienthead and neck cancerradiotherapypurple sweet potato

Outcome Measures

Primary Outcomes (4)

  • weight change

    The differences in body weight after and before the intervention was given. Weight in kilograms will be measured with digital scales Omron Type HBF 378.

    immediately after the intervention

  • Body mass index (BMI)

    Calculation of nutritional status using the ratio of body weight (kg) to height squared (m2), where body weight is measured using an digital scales Omron Type HBF 378 and height is measured with a stadiometer.

    immediately after the intervention

  • mid-upper arm circumference (MUAC)

    the circumference of the left upper arm, measured at the mid-point between the tip of the shoulder and the tip of the elbow (olecranon process and the acromion). MUAC is measured using a metline in centimeters.

    immediately after the intervention

  • handgrip strength

    a simple and reliable measurement of maximum voluntary muscle strength, that is measured with handgrip dynamometer in kilograms (kg) unit.

    immediately after the intervention

Study Arms (2)

immunonutrients ONS

EXPERIMENTAL

the intervention group received ONS which contained immunonutrients (omega 3 and anthocyanin)

Dietary Supplement: immunonutrients oral nutritional supplements

standard ONS

ACTIVE COMPARATOR

the control group received standard ONS (isocaloric)

Dietary Supplement: standard oral nutritional supplements

Interventions

1 serving of ONS immunonutrients which is 57 grams of ready-to-brew powder yields 200 ml of a liquid formula containing 251 kcal energy (1.26 kcal/ml), 9 grams protein (14%), 94 mg omega-3, and 20 mg anthocyanins.

immunonutrients ONS

1 serving of standard ONS which is 57 grams of ready-to-brew powder yields 200 ml of liquid formula containing 258 kcal energy (1.26 kcal/ml), 5 g (7.5%) protein , 7 g (24%) fat, 43 g (68%) carbohydrate

standard ONS

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant diagnosed with advanced stage head and neck cancer (stages 3 and 4) who received radiotherapy, both as concurrent and adjuvant or chemoradiotherapy
  • Participant aged 18-80 years
  • Participant can consume food, either through a nasogastric tube (NGT) or orally

You may not qualify if:

  • Participant has a milk or egg allergy
  • Participant with comorbid renal impairment and/or diabetes mellitus
  • Participant with poor nutritional status with BMI \< 17.0 kg/m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

dr. Sardjito General Hospital

Yogyakarta, DI Yogyakarta, 55284, Indonesia

RECRUITING

MeSH Terms

Conditions

Head and Neck Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasms

Study Officials

  • Fuadiyah Nila, MPH

    Gadjah Mada University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
University of Brawijaya

Study Record Dates

First Submitted

February 6, 2023

First Posted

February 23, 2023

Study Start

March 15, 2022

Primary Completion

April 30, 2023

Study Completion

May 30, 2023

Last Updated

February 24, 2023

Record last verified: 2023-02

Locations